EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials



In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials



Gastroenterology 110(4 SUPPL ): A295




(PDF emailed within 1 workday: $29.90)

Accession: 031865443

Download citation: RISBibTeXText



Related references

Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Alimentary Pharmacology & Therapeutics 11(6): 1131-1136, 1997

Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Alimentary Pharmacology & Therapeutics 11(6): 1131-1136, 1998

In vitro susceptibility of pretreatment isolates of H pylori from a multicenter US clinical trial. American Journal of Gastroenterology 89(8): 1390, 1994

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. American Journal of Gastroenterology 93(11): 2106-2112, 1998

CagA status and antimicrobial susceptibility in Helicobacter pylori pre- and post-treatment Spanish clinical isolates. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 121, 1997

Treatment of Helicobacter pylori Infection in Clinical Practice in the United States. Digestive Diseases and Sciences 45(2): 265-271, 2000

Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. Digestive Diseases and Sciences 45(2): 265-271, 2000

Treatment of Helicobacter pylori infection in clinical practice in the United States Results from 224 patients. Gastroenterology 116(4 PART 2): A69, April, 1999

In vitro susceptibility to voriconazole of 566 clinical isolates of Cryptococcus neoformans from Africa and the United States. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 451, 1998

Susceptibility of isolates from a multicenter Argentine study to evaluate eradication of Helicobacter pylori in patients with gastritis or active duodenal ulcers. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 92, 1996

Helicobacter pylori in vitro susceptibility to antibiotics in Portugal A multicenter study. Gut 47(Supplement 1): A10, October, 2000

A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: A United States, multicenter trial. American Journal of Gastroenterology 94(6): 1512-1516, June, 1999

Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clinical and Diagnostic Laboratory Immunology 9(1): 167-175, 2002

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. International Journal of Antimicrobial Agents 12(4): 341-347, 1999

The 13C-urea blood test accurately detects active Helicobacter pylori infection: A United States, multicenter trial. American Journal of Gastroenterology 94(6): 1522-1524, June, 1999